ARTICLE | Clinical News
Oncor regulatory update
October 30, 1995 8:00 AM UTC
The FDA will review on Nov. 30 the Gaithersburg, Md., company's PMA for its in vitro diagnostic genetic test system for HER-2/neu. The test is intended to aid in predicting the likelihood of disease r...